Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation and Employee Benefit Plan - Schedule of Stock Option Activity (Details)

v3.21.1
Stock-Based Compensation and Employee Benefit Plan - Schedule of Stock Option Activity (Details) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]    
Weighted Average Exercise Price at beginning $ 0.69 $ 0.72
Weighted Average Exercise Price, Granted 0.10 0.70
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Cancelled/expired 0.54 0.73
Weighted Average Exercise Price at ending 0.66 $ 0.69
Weighted Average Exercise Price, Vested and exercisable at end $ 0.65  
Number of Optioned Shares at beginning 1,575,000 750,000
Number of Optioned Shares, Granted 90,000 1,500,000
Number of Optioned Shares, Exercised
Number of Optioned Shares , Forfeited/expired/canceled (25,000) (675,000)
Number of Optioned Shares at end 1,640,000 1,575,000
Number of Optioned Shares, Vested and exercisable at end 1,265,000  
Weighted Average Remaining Contractual Term in Years at beginning 3 years 9 months 25 days 1 year 2 months 12 days
Weighted Average Remaining Contractual Term in Years, at end 2 years 9 months 29 days 3 years 9 months 25 days
Weighted Average Remaining Contractual Term in Years, Vested and exercisable at end 2 years 6 months 29 days  
Weighted Average Optioned Grant Date Fair Value at beginning $ 0.04 $ 0.24
Weighted Average Optioned Grant Date Fair Value, Granted 0.06 0.03
Weighted Average Optioned Grant Date Fair Value, Exercised
Weighted Average Optioned Grant Date Fair Value, Cancelled/expired 0.19 0.25
Weighted Average Optioned Grant Date Fair Value at end 0.04 $ 0.04
Weighted Average Optioned Grant Date Fair Value, Vested and exercisable at end $ 0.04  
Aggregate Intrinsic Value at beginning
Aggregate Intrinsic Value at end
Aggregate Intrinsic Value Vested and exercisable at end